European Archives - Page 906 of 1056 - European Medical Journal

Ethical Issues on Awake Thoracic Surgery for Seriously Chronically Ill Patients

Patients of any age with a serious progressive illness and a limited life expectancy that ranges up to a few years can be managed by palliative care.

Endoscopic Management of Sessile Serrated Polyps of the Colon

The scope of this short review is to discuss the current state of practice in detection and removal of sessile serrated polyps (SSPs) during…

Regorafenib in Advanced and Refractory Gastrointestinal Cancers

Summary of Presentations from the ESMO 18th World Congress on Gastrointestinal Cancer held in Barcelona, Spain from 28th June–2nd July 2016

Optimising Cancer Immunotherapy: Challenges and Opportunities

Cancer immunotherapy has moved to the forefront in the treatment of patients with cancer, providing a unique opportunity to achieve dramatic and…

Challenges and Considerations in the Management of Hyperkalaemia in Patients With Chronic Kidney Disease

Prof David Goldsmith opened the symposium by highlighting the objectives of the meeting. The education objectives of the symposium were to summarise the…

Editor’s Pick: Clinical Management of Fibromyalgia and the Continuum of Polysymptomatic Distress Disorders

The evaluation of patients with fibromyalgia (FM) and other functional somatic syndromes can appear intimidating, but a high index of suspicion and a…

Avanafil: The Second-Generation Treatment of Erectile Dysfunction

The main objectives of erectile dysfunction (ED) management are to control and reduce associated organic cardiovascular risk factors and to restore the…

New Evidence for Exogenous Glycosaminoglycans Treatment of ‘Cystitis': Is the Future Now?

Chronic cystitis may be due to different known causes. Current basic science research has revealed a wide consensus that chronic cystitis may arise from…

The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola

On January 14th 2016, SB4 (Benepali®) received marketing authorisation application approval from the European Commission (EC). It is the first biosimilar…

Late and Very Late Stent Thrombosis in the Era of Second-Generation Drug-Eluding Stents

Stent thrombosis is a life-threatening complication of percutaneous coronary intervention that often results in ST-segment myocardial infarction or …